Previous 10 | Next 10 |
2023-06-26 11:00:28 ET Summary The bioprocessing market is currently in a downturn and pulling companies like Danaher and Sartorius down. Danaher has a clean balance sheet to make good deals in this downturn. Margins have temporary headwinds but should recover in 2024. At ...
2023-06-25 10:28:54 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2023-06-22 07:50:04 ET Summary Danaher's bioprocessing business faces short-term challenges in 2023, but the company remains a strong investment opportunity in the Medtech sector. The company's razor-blade business model, leading positions in attractive end markets, and strong org...
2023-06-20 20:45:00 ET Summary Cytek Biosciences is a leader in full spectrum flow cytometry (FSFC), with innovative and cost-effective instruments used in various industries. The company's focus on customer-centric solutions and high-margin reagent business make it an attractive ...
Danaher Schedules Second Quarter 2023 Earnings Conference Call PR Newswire WASHINGTON , June 20, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2023 on Tuesd...
2023-06-20 08:47:00 ET The Bill and Melinda Gates Foundation Trust is a relatively concentrated portfolio for a trust with $36.5 billion invested. According to its last SEC filing, it only holds 22 stocks, so it's definitely not an index "tracker." As such, it's worth monitoring every stock...
2023-06-19 09:00:00 ET Summary Tech stocks have staged a massive comeback in 2023, but value investors should consider looking into currently unloved sectors like healthcare. The healthcare sector has underperformed in 2023, but the long-term outlook remains solid despite near-ter...
2023-06-16 10:45:50 ET Maravai LifeSciences ( NASDAQ: MRVI ) rose 2.2% amid a report of takeover interest from a strategic buyer for the vaccine reagent vendor. An unidentified strategic buyer is said to be competing with private equity firm Thomas H. Lee for Maravai ( M...
2023-06-14 09:38:00 ET Summary RGA Investment Advisors are an independent, fee-only investment management firm providing wealth management and financial planning for individuals, families, non-profit firms, and corporations of all sizes. The first quarter of 2023 was marked by a p...
2023-06-13 07:50:03 ET Summary My passive income stream increased by 25.59% YoY in April 2023 and 40.02% YoY in May 2023, with a year-to-date growth of 29.99%. I have been taking advantage of high yields on money market funds and short-term treasury ETFs, transitioning about 6.5% ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...